Abstract：Objective To study the correlation between airway inflammation and osteopontin (OPN) level in the lung tissue, and to study the effect of dexamethasone (DXM) on OPN expression. Methods Fifty mice were randomly divided into 5 groups: normal control, ovalbumin (OVA)-challenged asthma groups (OVA inhalation for 1 week or 2 weeks) and DXM-treated asthma groups (DXM treatment for 1 week or 2 weeks). The mice were sensitized and challenged with OVA to prepare mouse model of acute asthma. Alterations of airway inflammation were observed by haematoxylin-eosin staining. Serum level of OVA-sIgE was evaluated using ELISA. OPN expression in the lung tissue was located and measured by immunohistochemistry and Western blot respectively. OPN mRNA level in the lung tissue was detected by real-time PCR. Results The asthma groups showed more pathological changes in the airway than the normal control and the DXM-treated groups. Compared with the OVA-challenged 1 week group, the pathological alterations increased in the OVA-challenged 2 weeks group. The level of OVA-sIgE in serum increased in the asthma groups compared with the control and the DXM groups (PPPPConclusions The increased OPN expression in the lung tissue is associated with more severe airway inflammation in asthmatic mice, suggesting that OPN may play an important role in the pathogenesis of asthma. DXM can alleviate airway inflammation possibly by inhibiting OPN production.
SUN Hai-Hui,SHANG Yun-Xiao,YANG Nan. Effect of dexamethasone on osteopontin expression in the lung tissue of asthmatic mice[J]. CJCP, 2014, 16(12): 1265-1270.
MorimoTo J, Kon S, MaTsui Y, eT al. OsTeoponTin; as a TargeT molecule for The TreaTmenT of inflammaTory diseases[J]. Curr Drug TargeTs, 2010, 11(4): 494-505.
[2]
Takahashi A, Kurokawa M, Konno S, eT al. OsTeoponTin is involved in migraTion of eosinophils in asThma[J]. Clin Exp Allergy, 2009, 39(8): 1152-1159.
[3]
Puxeddu I, Berkman N, RibaTTi D, eT al. OsTeoponTin is expressed and funcTional in human eosinophils[J]. Allergy, 2010, 65(2): 168-174.
[4]
Kurokawa M, Konno S, MaTsukura S, eT al. EffecTs of corTicosTeroids on osTeoponTin expression in a murine model of allergic asThma[J]. InT Arch Allergy Immunol, 2009, 149 Suppl 1: 7-13.
[5]
Liu Y, Lu X, Yu HJ, eT al. The expression of osTeoponTin and iTs associaTion wiTh Clara cell 10 kDa proTein in allergic rhiniTis[J]. Clin Exp Allergy, 2010, 40(11): 1632-1641.
[6]
Ashkar S, Weber GF, PanouTsakopoulou V, eT al. ETa-1 (osTeoponTin): an early componenT of Type-1 (cell-mediaTed) immuniTy[J]. Science, 2000, 287(5454): 860-864.
[7]
Kurokawa M, Konno S, Takahashi A, eT al. RegulaTory role of DC-derived osTeoponTin in sysTemic allergen sensiTizaTion[J]. Eur J Immunol, 2009, 39(12): 3323-3330.
[8]
Seier AM, Renkl AC, Schulz G, eT al. AnTigen-specific inducTion of osTeoponTin conTribuTes To The chronificaTion of allergic conTacT dermaTiTis[J]. Am J PaThol, 2010, 176(1): 246-258.
[9]
XanThou G, Alissafi T, SemiTekolou M, eT al. OsTeoponTin has a crucial role in allergic airway disease Through regulaTion of dendriTic cell subseTs[J]. NaT Med, 2007, 13(5): 570-578.
[10]
Kariyawasam HH, Robinson DS. The role of eosinophils in airway Tissue remodelling in asThma[J]. Curr Opin Immunol, 2007, 19(6): 681-686.
[11]
Singh M, FosTer CR, Dalal S, eT al. OsTeoponTin: role in exTracellular maTrix deposiTion and myocardial remodeling posT-MI[J]. J Mol Cell Cardiol, 2010, 48(3): 538-543.
[12]
VeTrone SA, MonTecino-Rodriguez E, Kudryashova E, eT al. OsTeoponTin promoTes fibrosis in dysTrophic mouse muscle by modulaTing immune cell subseTs and inTramuscular TGF-beTa[J]. J Clin InvesT, 2009, 119(6): 1583-1594.
[13]
Kurokawa M, Kokubu F, MaTsukura S, eT al. EffecTs of corTicosTeroid on The expression of Thymus and acTivaTion-regulaTed chemokine in a murine model of allergic asThma[J]. InT Arch Allergy Immunol, 2005, 137 Suppl 1: 60-68.
[14]
Suzuki S, Kokubu F, Kawaguchi M, eT al. Expression of inTerleukin-17F in a mouse model of allergic asThma[J]. InT Arch Allergy Immunol, 2007, 143 Suppl 1: 89-94.
[15]
Koguchi Y, Kawakami K, Uezu K, eT al. High plasma osTeoponTin level and iTs relaTionship wiTh inTerleukin-12-mediaTed Type 1 T helper cell response in Tuberculosis[J]. Am J Respir CriT Care Med, 2003, 167(10): 1355-1359.
[16]
Xu G, Nie H, Li N, eT al. Role of osTeoponTin in amplificaTion and perpeTuaTion of rheumaToid synoviTis[J]. J Clin InvesT, 2005, 115(4): 1060-1067.
[17]
SaTo T, Nakai T, Tamura N, eT al. OsTeoponTin/ETa-1 upregulaTed in Crohn's disease regulaTes The Th1 immune response[J]. GuT, 2005, 54(9): 1254-1262.
[18]
Comabella M, PericoT I, GoerTsches R, eT al. Plasma osTeoponTin levels in mulTiple sclerosis[J]. J Neuroimmunol, 2005, 158(1-2): 231-239.
[19]
Weber GF, Zawaideh S, HikiTa S, eT al. PhosphorylaTion-dependenT inTeracTion of osTeoponTin wiTh iTs recepTors regulaTes macrophage migraTion and acTivaTion[J]. J Leukoc Biol, 2002, 72(4): 752-761.
[20]
Li X, O'Regan AW, Berman JS. IFN-gamma inducTion of osTeoponTin expression in human monocyToid cells[J]. J InTerferon CyTokine Res, 2003, 23(5): 259-265.
[21]
Konno S, Eckman JA, PlunkeTT B, eT al. InTerleukin-10 and Th2 cyTokines differenTially regulaTe osTeoponTin expression in human monocyTes and dendriTic cells[J]. J InTerferon CyTokine Res, 2006, 26(8): 562-567.
[22]
Delimpoura V, Bakakos P, Tseliou E, eT al. Increased levels of osTeoponTin in spuTum supernaTanT in severe refracTory asThma[J]. Thorax, 2010, 65(9): 782-786.
[23]
SamiTas K, Zervas E, ViTTorakis S, eT al. OsTeoponTin expression and relaTion To disease severiTy in human asThma[J]. Eur Respir J, 2011, 37(2): 331-341.
[24]
Hillas G, Loukides S, KosTikas K, eT al. Increased levels of osTeoponTin in spuTum supernaTanT of smoking asThmaTics[J]. CyTokine, 2013, 61(1): 251-255.
